Improved Outcome of Elderly Poor-Prognosis DLBCL Patients with 6xCHOP-14 and 8 Applications of Rituximab (R) Given Over An Extended Period: Results of the SMARTE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
暂无分享,去创建一个
M. Pfreundschuh | M. Reiser | S. Zeynalova | G. Held | M. Löffler | A. Viardot | U. Keller | N. Murawski | M. Hänel | V. Pöschel | M. Hänel